CHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CHD 9 | 2011 | 12146 | 12999 | 93.4% | |
| CHD 9 | 2012 | 11849 | 12727 | 93.1% | |
| CHD 9 | 2013 | 11522 | 12366 | 93.2% | |
| CHD005 | 2014 | 11262 | 11726 | 96.0% | |
| CHD005 | 2015 | 11054 | 11442 | 96.6% | |
| CHD005 | 2016 | 10812 | 11179 | 96.7% | |
| CHD005 | 2017 | 10762 | 11125 | 96.7% | |
| CHD005 | 2018 | 10480 | 10874 | 96.4% | |
| CHD005 | 2019 | 10137 | 10516 | 96.4% | |
| CHD005 | 2020 | 9955 | 10343 | 96.2% | |
| CHD005 | 2021 | 9584 | 10370 | 92.4% | |
| CHD005 | 2022 | 9532 | 10173 | 93.7% | |
| CHD005 | 2023 | 9484 | 9887 | 95.9% |
